版本:
中国

BRIEF-Asterias Biotherapeutics announced new positive serial magnetic resonance imaging data

May 11 Asterias Biotherapeutics Inc:

* Asterias Biotherapeutics- announced new positive serial magnetic resonance imaging data from its ongoing ast-opc1 scistar phase 1/2a clinical trial

* Asterias Biotherapeutics- patients are monitored by MRI scans at regular intervals over 12 months in order to assess status of injection site, surrounding tissues Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐